3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
3
Fallopian Tube Neoplasms
2
Colorectal Neoplasms
2
Triple Negative Breast Neoplasms
1
Solid Tumors
1
Sarcoma
1
Recurrence
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Neoplasms
1
Neoplasm Metastasis
1
Liver Neoplasms
1
Glioblastoma
1
Gastrointestinal Neoplasms
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms
1
Advanced Adult Hepatocellular Carcinoma
1
Interventions
Platinum
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Cisplatin
2
Biopsy
2
1,2-diaminocyclohexaneplatinum II citrate
2
rocakinogene sifuplasmid
1
fludarabine phosphate
1
fludarabine
1
durvalumab
1
alovudine
1
aldesleukin
1
Vaccines, Synthetic
1
VGX-3100
1
Sonazoid
1
Respiratory Function Tests
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy, Conformal
1
Radiosurgery
1
Prochlorperazine
1
Positron-Emission Tomography
1
Ondansetron
1
O(6)-codeine methyl ether
1
Meperidine
1
Magnetic Resonance Imaging
1
MEDI0457
1
Loperamide
1
Interleukin-2
1
Innovar
1
Indomethacin
1
Immunoglobulin G
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Vulvar Neoplasms
×
tivozanib
×
Clear all
No trials found.